Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents.
ADME
androgen receptor
benzohydrazide
molecular docking
molecular dynamics
prostate cancer
Journal
Frontiers in chemistry
ISSN: 2296-2646
Titre abrégé: Front Chem
Pays: Switzerland
ID NLM: 101627988
Informations de publication
Date de publication:
2019
2019
Historique:
received:
03
04
2019
accepted:
20
06
2019
entrez:
30
7
2019
pubmed:
30
7
2019
medline:
30
7
2019
Statut:
epublish
Résumé
Prostate Cancer (PCa) is the most frequently diagnosed cancer in men in their late '50s. PCa growth is mainly due to the activation of the androgen receptor by androgens. The treatment for PCa may involve surgery, hormonal therapy, and oral chemotherapeutic drugs. A structural based molecular docking approach revealed the findings of
Identifiants
pubmed: 31355179
doi: 10.3389/fchem.2019.00474
pmc: PMC6636335
doi:
Types de publication
Journal Article
Retracted Publication
Langues
eng
Pagination
474Commentaires et corrections
Type : ErratumIn
Type : RetractionIn
Références
Oncogene. 2002 Aug 12;21(35):5361-79
pubmed: 12154399
Leuk Lymphoma. 2003 Nov;44(11):1957-62
pubmed: 14738150
Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6201-6
pubmed: 15833816
Bioorg Med Chem Lett. 2006 Jan 1;16(1):31-5
pubmed: 16263280
Eur J Med Chem. 2006 Nov;41(11):1253-61
pubmed: 16919372
Bioorg Med Chem Lett. 2009 May 15;19(10):2710-3
pubmed: 19369076
Eur J Med Chem. 2009 Oct;44(10):3954-60
pubmed: 19464085
J Med Chem. 2010 Apr 8;53(7):2779-96
pubmed: 20218717
Lancet. 2010 Apr 24;375(9724):1437-46
pubmed: 20398925
Int J Cancer. 2010 Dec 15;127(12):2893-917
pubmed: 21351269
Vaccine. 2012 Jun 19;30(29):4394-7
pubmed: 22122856
Cancer Res. 2012 Mar 15;72(6):1494-503
pubmed: 22266222
Hum Vaccin Immunother. 2012 Apr;8(4):520-7
pubmed: 22370520
Eur J Med Chem. 2012 May;51:124-36
pubmed: 22405287
J Med Chem. 2012 Oct 11;55(19):8225-35
pubmed: 22897611
Chem Asian J. 2012 Nov;7(11):2670-7
pubmed: 22945790
Eur J Med Chem. 2012 Dec;58:573-80
pubmed: 23174316
J Clin Oncol. 2013 Oct 1;31(28):3525-30
pubmed: 24002508
J Med Chem. 2013 Nov 14;56(21):8280-97
pubmed: 24044500
Int J Mol Sci. 2014 Nov 24;15(11):21587-602
pubmed: 25421248
Acta Crystallogr C Struct Chem. 2015 Jan;71(Pt 1):3-8
pubmed: 25567568
Sci Rep. 2016 Mar 15;6:23077
pubmed: 26975752
Molecules. 2016 Aug 03;21(8):
pubmed: 27527130
Eur J Med Chem. 2016 Nov 29;124:445-455
pubmed: 27598233
Pharmaceuticals (Basel). 2010 Mar 25;3(4):810-838
pubmed: 27713281
Bioorg Med Chem Lett. 2017 Mar 1;27(5):1199-1204
pubmed: 28162857
Med Chem Res. 2017;26(2):287-301
pubmed: 28163562
J Med Chem. 2017 Apr 13;60(7):3082-3093
pubmed: 28272894
Anticancer Agents Med Chem. 2017;17(13):1756-1768
pubmed: 28403781
Chem Biol Interact. 2017 Sep 25;275:22-34
pubmed: 28757136
Asian J Androl. 2018 May-Jun;20(3):213-214
pubmed: 29536949
Cancer Res. 2018 Jul 15;78(14):4022-4035
pubmed: 29764864
Eur J Med Chem. 2019 Apr 15;168:1-10
pubmed: 30798049
Anticancer Drug Des. 1995 Mar;10(2):155-66
pubmed: 7710636
Phys Rev A Gen Phys. 1985 Mar;31(3):1695-1697
pubmed: 9895674